Proof of principle data from Phase I part of the Phase I/II trial of TG4050 in the adjuvant setting of head and neck cancer. All TG4050-treated patients remained disease-free after median follow-up of ...
A new type of ‘vaccine scepticism’ has been uncovered by researchers at Lancaster University, who examined a ...
Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or ...
New biomarker and immune data from the ongoing phase 2 trial with EVX-01 will be presented at the American Association for Cancer Research (AACR) ...
New non-clinical data strengthens evidence of contributions of IO102 and IO103 to tumor growth control through target specific T-cell activation, offering a distinct and complementary approach to ...
The California Department of Public Health has released its annual report on vaccination rates for California students. The ...
A hypoallergenic therapeutic vaccine candidate for peanut allergy was safe and tolerable, according to a poster presented at ...
New character posters for the second season of The Last of Us feature a reference to the video games that inspired the HBO series.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback